Lipid Mediators of Inflammation and Resolution in Individuals with Tuberculosis and Tuberculosis-Diabetes

Individuals with concurrent tuberculosis (TB) and Type 2 diabetes (DM) have a higher risk of adverse outcomes. To better understand potential immunological differences, we utilized a comprehensive panel to characterize pro-inflammatory and pro-resolving (i.e., mediators involved in the resolution of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Prostaglandins Other Lipid Mediat
Autores principales: Shivakoti, Rupak, Dalli, Jesmond, Kadam, Dileep, Gaikwad, Sanjay, Barthwal, Madhusudan, Colas, Romain A., Mazzacuva, Francesca, Lokhande, Rahul, Dharmshale, Sujata, Bharadwaj, Renu, Kagal, Anju, Pradhan, Neeta, Deshmukh, Sona, Atre, Sachin, Sahasrabudhe, Tushar, Kakrani, Arjun, Kulkarni, Vandana, Raskar, Swapnil, Suryavanshi, Nishi, Chon, Sandy, Gupte, Akshay, Gupta, Amita, Gupte, Nikhil, Arriaga, María B., Fukutani, Kiyoshi F., Andrade, Bruno B., Golub, Jonathan E., Mave, Vidya
Formato: Artigo
Lenguaje:Inglês
Publicado: 2019
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7067657/
https://ncbi.nlm.nih.gov/pubmed/31726221
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.prostaglandins.2019.106398
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares